利用生物信息学探索脓毒症中与预后相关的坏死性凋亡基因及其潜在机制
该研究利用GEO数据集GSE65682和GSE134347,通过Kaplan-Meier和ROC分析识别出6个具有生存和诊断意义的坏死性凋亡相关基因生物标志物(ATRX、TSC1、CD40、BACH2、BCL2、LEF1)。IPA分析提示这些基因富集于肝纤维化通路和BEX2蛋白。分子调控网络显示hsa-miR-5195-3p和hsa-miR-145-5p调控ATRX、BACH2和CD40,YY1同时控制LEF1、ATRX、BCL2、BACH2和CD40。CD40与RIPK3和MLKL表达模式相似,LEF1与MLKL功能相关。DrugBank分析识别出紫杉醇、多西他赛和雷沙吉兰为潜在靶向BCL2的脓毒症治疗药物。实时定量PCR证实脓毒症样本中ATRX、TSC1和LEF1下调,而CD40在CTL样本中表达增高。作者认为这些基因可能是脓毒症坏死性凋亡的关键调控靶点,为后续研究提供基础。
要点
- 基于GEO数据集GSE65682和GSE134347,通过Kaplan-Meier和ROC分析识别出6个具有生存和诊断意义的坏死性凋亡相关基因:ATRX、TSC1、CD40、BACH2、BCL2、LEF1。
- IPA分析提示这些基因富集于肝纤维化通路和BEX2蛋白。
- 分子调控网络显示hsa-miR-5195-3p和hsa-miR-145-5p调控ATRX、BACH2和CD40,YY1同时控制LEF1、ATRX、BCL2、BACH2和CD40。
- CD40与RIPK3和MLKL表达模式相似,LEF1与MLKL功能相关。
- DrugBank分析识别出紫杉醇、多西他赛和雷沙吉兰为潜在靶向BCL2的脓毒症治疗药物。
研究设计与关键结果
- 研究类型:生物信息学分析,使用GEO数据集GSE65682和GSE134347。
- 通过Kaplan-Meier和ROC分析识别出6个具有生存和诊断意义的坏死性凋亡相关基因生物标志物:ATRX、TSC1、CD40、BACH2、BCL2、LEF1。
- IPA分析提示这些基因富集于肝纤维化通路和BEX2蛋白。
- 分子调控网络显示hsa-miR-5195-3p和hsa-miR-145-5p调控ATRX、BACH2和CD40,YY1同时控制LEF1、ATRX、BCL2、BACH2和CD40。
- CD40与RIPK3和MLKL表达模式相似,LEF1与MLKL功能相关。
- DrugBank分析识别出紫杉醇、多西他赛和雷沙吉兰为潜在靶向BCL2的脓毒症治疗药物。
- 实时定量PCR证实脓毒症样本中ATRX、TSC1和LEF1下调,而CD40在CTL样本中表达增高。
证据类型、等级与局限
- 证据类型:生物信息学分析(基于公共基因表达数据集)。
- 局限:原文未报告局限性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Sepsis is a life-threatening disease due to a dysregulated host response to infection, with an unknown regulatory mechanism for prognostic necroptosis-related genes (NRGs). Using GEO datasets GSE65682 and GSE134347, we identified six NRG biomarkers ( ATRX , TSC1 , CD40 , BACH2 , BCL2 , and LEF1 ) with survival and diagnostic significance through Kaplan-Meier (KM) and receiver operating characteristic (ROC) analyses. Afterward, the ingenuity pathway analysis (IPA) highlighted enrichment in hepatic fibrosis pathways and BEX2 protein. Moreover, we examined their regulatory targets and functional links with necroptotic signaling molecules via miRDB, TargetScan, Network analyst, and GeneMANIA. The molecular regulatory network displayed that hsa-miR-5195-3p and hsa-miR-145-5p regulated ATRX, BACH2, and CD40, while YY1 showed strong connectivity, concurrently controlling LEF1, ATRX, BCL2, BACH2, and CD40. CD40 exhibited similar expression patterns to RIPK3 and MLKL, and LEF1 was functionally associated with MLKL. Additionally, DrugBank analysis identified paclitaxel, docetaxel, and rasagiline as potential BCL2-targeting sepsis treatments. Finally, real-time quantitative PCR confirmed ATRX, TSC1, and LEF1 downregulation in sepsis samples, contrasting CD40's increased expression in CTL samples. In conclusion, ATRX , TSC1 , CD40 , BACH2 , BCL2 , and LEF1 may be critical regulatory targets of necroptosis in sepsis, providing a basis for further necroptosis-related studies in sepsis.
参考来源
- Liu J, Li L, He S, et al. EXPLORING THE PROGNOSTIC NECROPTOSIS-RELATED GENES AND UNDERLYING MECHANISM IN SEPSIS USING BIOINFORMATICS. Shock. 2024. PMID: 38920136. doi:10.1097/SHK.0000000000002414
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。